HELP
Helus Pharma Inc.Pre-market10.50−0.53 −4.81%USD
NasdaqGM · as of Oct 13, 16:00 ET · 15m delayPre-market 10.68 +1.71%
Open
11.03
Prev close
11.03
Day range
9.9711.04
52-week range
3.7615.15
Volume
3.16M1.77×
Mkt cap
767.13M
P/E ttm
—
Fwd P/E
-5.90
EPS ttm
-4.15
Div yield
0.00%
Earnings
Aug 14, 2026
From 52w high
−30.69%
HELP earnings and estimates
HELP Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 12
Before the open · estimated
EPS consensus
$−0.95
range −1.17 – −0.57
EPS growth vs year ago
+42.7%
year ago −1.65
Revenue consensus
$0
0.0% vs year ago
Options-implied move
±38.6%
by Nov 20 · ATM straddle
Past 4 reactions
±5.5%
average move · beat 1 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 14, 2026 BMO | −1.26 | −1.38 | +8.37% | — | +4.7% | +8.9% |
| Mar '26 | Jun 29, 2026 BMO | −1.21 | −1.14 | −5.77% | $0 | +6.2% | −9.1% |
| Dec '25 | Feb 13, 2026 BMO | −1.36 | −0.98 | −39.79% | $0 | +2.9% | +15.0% |
| Sep '25 | Nov 13, 2025 BMO | −1.65 | −1.33 | −24.53% | $0 | −8.0% | −8.2% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.95 | −1.17−0.57 | +42.7% | $0 | 0.0% | −0.94 −0.3% | −1.09 +13.3% | 0 / 1 |
| Next quarter Dec 2026 | −0.88 | −1.07−0.64 | +35.4% | $0 | 0.0% | −0.88 −0.3% | −1.11 +20.5% | 0 / 1 |
| Current year Mar 2027 | −3.72 | −4.43−2.86 | +37.1% | $0 | 0.0% | −3.71 −0.4% | −4.43 +16.1% | 0 / 1 |
| Next year Mar 2028 | −2.54 | −3.04−2.04 | +31.7% | $11.07M | 0.0% | −3.30 +23.1% | −3.97 +36.0% | 1 / 1 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.67 | — | 1 | 0 / 0 |
| Dec 2026 | −0.68 | — | 1 | 0 / 0 |
| Mar 2027 | −0.59 | — | 1 | 0 / 0 |
| Jun 2027 | −0.59 | — | 1 | 0 / 0 |
| Sep 2027 | −0.53 | — | 1 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Mar 2027 | −2.95 | −3.27−2.78 | 3 | 0 / 0 |
| Mar 2028 | −2.19 | — | 1 | 0 / 0 |
| Mar 2029 | −1.09 | — | 1 | 0 / 0 |
| Mar 2030 | 0.62 | — | 1 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.